Usa India Britain Sweden covid-19 infection Immunic Usa India Britain Sweden

Covid-19: Britain approves this new therapy for those with weak immune response

Reading now: 833
www.livemint.com

Covid-19 treatment for adults with poor immune response. This marks a major step in the fight against the pandemic as infections surge globally amid spread of the Omicron variant.

The decision to grant approval for the treatment was endorsed by the government's independent scientific advisory body after reviewing the evidence, the Medicines and Healthcare products Regulatory Agency (MHRA) said on Thursday.

A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for Covid-19 prevention by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting the UK regulatory standards of safety, quality and effectiveness, as per the government release.

This comes amid figures showing a global rise in Covid-19 cases could herald a much bigger problem, the World Health Organization said this week, warning nations to remain vigilant as some countries also report a drop in testing rates.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA